Cookies
This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
George Poulogiannis is a Reader in Cancer Metabolism and Precision Medicine and Head of the Signalling and Cancer Metabolism laboratory at the Institute of Cancer Research, London. After earning his PhD from the University of Cambridge, where he studied the genome abnormalities of colorectal cancer at the laboratory of Andrew Wyllie and Mark Arends, George joined for his postdoc the group of Lew Cantley at Harvard Medical School to study the signalling and metabolic networks that are associated with the activation of the PI3K/Akt/mTOR pathway.
In 2014, he joined the faculty of ICR to lead the Signalling and Cancer Metabolism laboratory, and the research focus of his group is to understand the biochemical basis of metabolic reprogramming underlying cancer growth and progression with the ultimate goal to aid diagnostic stratification and identify novel targets for cancer prevention/therapy.
BACR is a registered charity in England and Wales (289297)
Registered address:
c/o Leeds Institute of Medical Research at St James’s, Cancer Genetics Building,
St James's University Hospital, Beckett Street, Leeds LS9 7TF
Home / Privacy Policy & Cookies / Terms of use / Site map / Admin
© 2018 - 2024 BACR - The British Association for Cancer Research. All rights reserved.
This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.